Quantrx Biomedical
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of h… Read more
Market Cap & Net Worth: Quantrx Biomedical (QTXB)
Quantrx Biomedical (PINK:QTXB) has a market capitalization of $39.35K ($39.35K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #43058 globally and #13832 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quantrx Biomedical's stock price $0.00 by its total outstanding shares 78696496 (78.70 Million).
Quantrx Biomedical Market Cap History: 2015 to 2025
Quantrx Biomedical's market capitalization history from 2015 to 2025. Data shows change from $2.12 Million to $39.35K (-34.52% CAGR).
Quantrx Biomedical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quantrx Biomedical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
13620.55x
Quantrx Biomedical's market cap is 13620.55 times its annual revenue
169.90x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.12 Million | $156.00 | -$467.78K | 13620.55x | N/A |
Competitor Companies of QTXB by Market Capitalization
Companies near Quantrx Biomedical in the global market cap rankings as of March 19, 2026.
Key companies related to Quantrx Biomedical by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Quantrx Biomedical Historical Marketcap From 2015 to 2025
Between 2015 and today, Quantrx Biomedical's market cap moved from $2.12 Million to $ 39.35K, with a yearly change of -34.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $39.35K | +150.00% |
| 2024 | $15.74K | -97.47% |
| 2023 | $621.70K | +12.86% |
| 2022 | $550.88K | -30.00% |
| 2021 | $786.96K | +66.67% |
| 2020 | $472.18K | +62.16% |
| 2019 | $291.18K | +60.87% |
| 2018 | $181.00K | -62.90% |
| 2017 | $487.92K | -10.14% |
| 2016 | $543.01K | -74.44% |
| 2015 | $2.12 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Quantrx Biomedical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.35K USD |
| MoneyControl | $39.35K USD |
| MarketWatch | $39.35K USD |
| marketcap.company | $39.35K USD |
| Reuters | $39.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.